Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Why Blockchain Works Explained Simply breaks down the core mechanics behind blockchain technology, focusing on trust, immutability, and network consensus.
19,902 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A Jordan base attack left two U.S. service members dead and one missing as tensions flare with Iran. The fallout hits...
Bitcoin is slipping into the weekend as macro pressures mount and a political cue looms. Traders watch critical suppo...
Microsoft stock has fallen about 27% from its all-time high, but long‑term catalysts could help it double by 2030. Th...
When headlines threaten to derail a stock you own, smart investors don’t panic. This guide explains how to evaluate M...
A retirement couple with a $1.4 million 401(K) saw 85% of their Social Security taxed due to long-standing income thr...
U.S. consumer discretionary stocks rise as demand improves in March 2026. Analysts cite pricing power and resilient c...
What if a $1,000 bet on COSTCO in 2006 rode all the way to today? This article breaks down the math, compares it to t...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...
A growing pattern in divorce settlements is eroding retirees' retirement savings, with home equity favored over tax-a...
BitMine disclosed a multi-billion ETH stake as it moves to a public listing, redefining how companies participate in ...
Analysts boosted price targets for Okta and Fortinet this week as cybersecurity budgets rise with AI integration. Rat...